Search

Your search keyword '"Galli, L."' showing total 3,128 results

Search Constraints

Start Over You searched for: Author "Galli, L." Remove constraint Author: "Galli, L."
3,128 results on '"Galli, L."'

Search Results

201. Prevalence and Clinical Outcomes of Poor Immune Response Despite Virologically Suppressive Antiretroviral Therapy Among Children and Adolescents With Human Immunodeficiency Virus in Europe and Thailand: Cohort Study

202. THE FRESHWATER CRAYFISH AUSTROPOTAMOBIUS PALLIPES (LEREBOULLET, 1858) IN LIGURIA, NW ITALY: IMPLICATIONS FOR MANAGEMENT AT THE REGIONAL LEVE

203. Sunitinib administered on 2/1 schedule in patients with metastatic renal cell carcinoma: the RAINBOW analysis

204. Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454 pyrosequencing

205. Factors associated with severity in invasive community-acquired Staphylococcus aureus infections in children: a prospective European multicentre study

206. Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: data from the ICONA cohort

208. 695P Drug-drug interactions between pazopanib and proton pump inhibitors may significantly affect clinical outcome of patients affected by metastatic renal cell carcinoma

209. 696P Is it possible to improve the prognostic ability of the IMDC score? Validation of the Meet-URO score in metastatic renal cell carcinoma (mRCC) patients (pts) receiving first-line nivolumab plus ipilimumab in the Italian Expanded Access Program (EAP)

210. 750P Safety and efficacy of platinum desensitization treatment in patients with ovarian cancer and platinum hypersensitivity

211. Enhancing the understanding of fragmentation processes in hadrontherapy and radioprotection in space with the FOOT experiment

212. The large scale polarization explorer (LSPE) for CMB measurements: performance forecast

214. P216 - Neutrophil-to-eosinophil ratio (NER) predicts the efficacy of avelumab in patients with advanced Urothelial Carcinoma (aUC) enrolled in the MALVA study (Meet-URO 25)

215. Safety and efficacy of nivolumab for metastatic renal cell carcinoma: real-world results from an expanded access programme

216. Effectiveness of dolutegravir-based regimens as either first-line or switch antiretroviral therapy: data from the Icona cohort

217. Italian consensus statement on paediatric HIV infection

218. Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Naïve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004-2014

219. Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy

223. Performance of the ToF detectors in the FOOT experiment

224. Susceptibility to HIV-1 integrase strand transfer inhibitors (INSTIs) in highly treatment-experienced patients who failed an INSTI-based regimen

225. Evolution of HIV-1 tropism at quasispecies level after 5 years of combination antiretroviral therapy in patients always suppressed or experiencing episodes of virological failure

227. Longitudinal analysis of HIV-1 coreceptor tropism by single and triplicate HIV-1 RNA and DNA sequencing in patients undergoing successful first-line antiretroviral therapy

228. Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection?

230. Gamma knife radiosurgery for uveal melanoma: 12 years of experience

231. HBcAb Positivity Increases the Risk of Severe Hepatic Fibrosis Development in HIV/HCV-Positive Subjects from the ICONA Italian Cohort of HIV-Infected Patients

232. Measuring the Impact of Nuclear Interaction in Particle Therapy and in Radio Protection in Space : the FOOT Experiment

237. 1895P Time to treatment failure (TTF) and treatment beyond progression (TBP) in pretreated metastatic renal cell carcinoma (mRCC) patients (pts) receiving nivolumab: A survival outcome and a therapeutic strategy of clinical benefit (meet-uro 15)

246. Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: An observational cohort study

247. Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline viro-immunological status and outcome in patients under first-line ART

248. Triglyceride/HDL ratio and its impact on the risk of diabetes mellitus development during ART

Catalog

Books, media, physical & digital resources